# Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack

> **NCT01438086** · PHASE1,PHASE2 · COMPLETED · sponsor: **University College Cork** · enrollment: 47 (actual)

## Conditions studied

- Heart Failure
- Myocardial Infarction

## Interventions

- **DRUG:** mecasermin
- **DRUG:** mecasermin
- **DRUG:** 0.9% sodium chloride injection

## Key facts

- **NCT ID:** NCT01438086
- **Lead sponsor:** University College Cork
- **Sponsor class:** OTHER
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2011-10
- **Primary completion:** 2016-02
- **Final completion:** 2016-12
- **Target enrollment:** 47 (ACTUAL)
- **Last updated:** 2017-03-30


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01438086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01438086, "Evaluation of the Safety and Efficacy of Using Insulin-like Growth Factor-1 in Patients With a Heart Attack". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT01438086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*